Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Business

CellaVision launches a new product for proficiency testing


Print article Print article
Copyright © Thomson Reuters 2013. All rights reserved.
2013-03-05 14:04:11 -

CellaVision, which develops and sells products for routine analysis of blood and
other body fluids in health care, is launching a new product for internal and
external quality assurance and proficiency testing of laboratory analyses. The
product, CellaVision® Proficiency Software, targets clinical laboratories that
assess and perform the classification of blood cells, as well as accredited
providers of external quality assessment schemes for laboratory medicine.

With CellaVision Proficiency Software, Medical Technologists train and test
their skills in performing peripheral blood and body fluid differential counts
and get instant feedback on their performance. The product promotes independent
learning and helps laboratories reduce their time and resources for quality
control, and creates an opportunity to increase the quality assessment of the
medical test results that provide a basis for patient care and treatment.

The 
product is web-based and designed to support organizations with many users. Located on a cloud server, the program can be run from any computer and any location without the need for software downloads. Users log in to their account through a web browser and can create, distribute and perform proficiency tests, track performance and compare the overall results. Linked to the product is a web portal with a free trial version of the product, www.cellavision-proficiency.com. At the web portal customers can participate in activities to test their knowledge of cell morphology, and interact with peers through the user forum. Because of the potential savings in both time and money, as well as the ability to add value to their end-users, great interest is being shown in this product by external quality assessment providers around the world. Currently, an evaluation of the product is being performed by the Swedish organization EQUALIS. The results from their pilot study will be presented at EQUALIS annual user meeting in March 7-8, 2013. CellaVision Proficiency Software is available in two versions and is sold directly by CellaVision as an annual license fee. The Professional Edition is designed for universities and laboratories with 10-100 users. The Enterprise Edition is specially adapted for integrated health networks and external quality assessment organizations with up to 2000 users. Product photo Product photos can be downloaded via the links below. For more information please contact: Emma Jacobsén, Product Manager, CellaVision AB Tel: +46 708 13 73 22. E-mail: emma.jacobsen@cellavision.com About CellaVision CellaVision is an innovative, global medical technology company that develops and sells its own leading systems for routine analysis of blood and other body fluids in health care services. The products rationalize manual laboratory work, and secure and support effective workflows and skills development within and between hospitals. The company has leading-edge expertise in image analysis, artificial intelligence and automated microscopy. In most countries sales are via global partners. Products are sold directly in the Nordic countries and via subsidiaries in the US, Canada and Japan. In 2012 sales were SEK 170 million and sales continue to increase, with a growth target of at least 15 % per year over an economic cycle. CellaVision's registered office is in Lund, Sweden. The share is listed on the Nasdaq OMX Stockholm, Small Cap list. Read more at www.cellavision.com. CellaVision Proficiency Software 2: hugin.info/132164/R/1683040/550707.jpg CellaVision Proficiency Software 1: hugin.info/132164/R/1683040/550706.jpg This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein. Source: CellaVision AB via Thomson Reuters ONE [HUG#1683040]


Press Information:




Contact Person:


Disclaimer: © 2014 Thomson Reuters. The press releases or report contained herein is protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Thomson Reuters's, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com | BidVertiser